蘭州黃河(000929.SZ):全資子公司擬使用自有閒置資金進行證券投資
格隆匯12月14日丨蘭州黃河(000929.SZ)公佈,為合理使用全資子公司閒置資金,提高公司資金收益,公司於2021年12月14日召開第十一屆董事會第六次會議,審議通過了《關於全資子公司使用自有閒置資金進行證券投資的議案》。
投資種類:新股配售或者申購、股票投資、債券投資、委託理財(含銀行理財產品、信託產品)以及深圳證券交易所認定的其他投資行為,不包含衍生品交易。
資金額度:人民幣1.5億元;投資取得的收益可進行再投資,再投資的金額不包含在初始投資的1.5億元以內;在該額度範圍內,用於投資的資本金可循環使用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.